prestige bio pbp1510 cancer
Scope
Date
~
-
Companies
CJ CheilJedang opens internal venture development space Inno Play
South Korea's food and bio giant CJ CheilJedang Corp. on Sunday said it opened Inno Play, an office space for commercializing innovative ideas and d...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
CJ CheilJedang invests in Australian bio startup
South Korea's food and bio company CJ CheilJedang Corp. on Wednesday said it will invest in the Australian bio startup Provectus Algae.The former se...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Korean stock market
S.Korean firms with focus on emerging Asia to shine
South Korean companies with a large proportion of sales to emerging Asia are expected to shine in the stock market this year as their revenue from t...
Feb 24, 2023 (Gmt+09:00)
-
Real estate
Korea's Cha Bio Group to expand overseas real estate business
Cha Bio Group, consisting of Cha Biotech and Cha Vaccine Research Institute as its subsidiaries, has announced its expansion into the real estate in...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
EOFlow's insulin injection pump starts to be sold in UAE
South Korea's medical device maker EOFlow Co. started selling the wearable insulin pump EOPatch in the United Arab Emirates.The company said on Tues...
Feb 15, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korea's Lunit supplies breast cancer imaging solution to UAE
South Korean medical AI company Lunit has supplied its breast cancer imaging analysis solution — Agfa HealthCare Enterprise Imaging — to...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials
Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung receives EU GMP certification
South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
UK's Croda to buy Korean bio materials maker for $286 mn
Croda International Plc., a British specialty chemicals company, is set to acquire South Korean bio materials producer Solus Biotech Co. for some 35...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio to launch precision cancer test service in Thailand
South Korean medical diagnostic company NGeneBio Co. has partnered with MP Group, a large consignment testing agency in Thailand, to launch a precis...
Feb 02, 2023 (Gmt+09:00)
-
Venture capital
Korea's venture capital investment falls 12% last year amid downturn
South Korea's venture capital investment last year fell more than 10% from a year ago due to the economic downturn caused by a series of global rate...
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
DongKoo Bio signs MOU to move into SE Asian healthcare market
DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, th...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Hancom Carelink invests in bio big data venture 3bigs
South Korea's Hancom Carelink, a digital health care company under Hancom Group, on Wednesday said it bought an unspecified stake in the bio big dat...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong accelerates investment in CDMO business
Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Inc. eyes significant growth in bio business from 2024
SAN FRANCISCO – SK Inc., the investment and holding company of South Korea’s SK Group, expects significant growth in its biopharma...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma attains patent for solid cancer treatment antibody
Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte to invest more in US bio biz, spend $3 bn in Korea
SAN FRANCISCO -- South Korea’s Lotte Biologics Co. is considering investing more in the US bio industry and spending $3 billion in new factori...
Jan 11, 2023 (Gmt+09:00)
-
Bio & Pharma
SK bio families to present visions to global investors at SK Bio Night
SK Inc., the investment company of SK Group, said on Tuesday that it will hold a networking event called "SK Bio Night" in the US along with its bio...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Hansol Chemical to enter bio industry with BiOCS acquisition
Hansol Chemical Co., a unit of South Korea’s paper-focused conglomerate Hansol Group, is expanding its business scope to biomaterials by acqui...
Dec 27, 2022 (Gmt+09:00)
-
Venture capital
Korea’s big bio startups to launch $39 mn investment fund
South Korea’s four leading biotech firms plan to launch an investment fund of up to 50 billion won ($39 million) to support smaller domestic b...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
KOICA donates Celltrion's Herzuma to Ukraine
Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...
Dec 26, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand